NEA Management Company as of June 30, 2023
Portfolio Holdings for NEA Management Company
NEA Management Company holds 44 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Coursera (COUR) | 12.8 | $168M | 13M | 13.02 | |
| Arcellx Common Stock (ACLX) | 9.0 | $118M | 3.7M | 31.62 | |
| Verona Pharma Sponsered Ads (VRNA) | 9.0 | $118M | 5.1M | 23.11 | |
| Crispr Therapeutics Namen Akt (CRSP) | 6.8 | $89M | 1.6M | 56.14 | |
| Savara (SVRA) | 5.9 | $77M | 24M | 3.19 | |
| Geron Corporation (GERN) | 5.2 | $69M | 21M | 3.21 | |
| Mirum Pharmaceuticals (MIRM) | 4.3 | $57M | 2.2M | 25.87 | |
| Berkshire Grey Com Cl A | 4.1 | $54M | 38M | 1.41 | |
| Monte Rosa Therapeutics (GLUE) | 4.0 | $53M | 7.7M | 6.85 | |
| Rhythm Pharmaceuticals (RYTM) | 3.7 | $48M | 2.9M | 16.49 | |
| Aurinia Pharmaceuticals (AUPH) | 2.9 | $38M | 4.0M | 9.68 | |
| CVRX (CVRX) | 2.8 | $37M | 2.4M | 15.44 | |
| Bright Health Group Com New (NEUE) | 2.5 | $33M | 2.7M | 12.22 | |
| X4 Pharmaceuticals (XFOR) | 2.2 | $29M | 15M | 1.94 | |
| Reneo Pharmaceuticals (RPHM) | 2.2 | $28M | 4.8M | 5.90 | |
| Trevi Therapeutics (TRVI) | 2.1 | $27M | 11M | 2.39 | |
| Allakos (ALLK) | 2.0 | $27M | 6.1M | 4.36 | |
| Desktop Metal Com Cl A | 1.9 | $26M | 14M | 1.77 | |
| Nextnav Common Stock (NN) | 1.8 | $24M | 8.2M | 2.94 | |
| Black Diamond Therapeutics (BDTX) | 1.7 | $23M | 4.4M | 5.05 | |
| Phathom Pharmaceuticals (PHAT) | 1.4 | $18M | 1.3M | 14.32 | |
| ZeroFox Holdings | 1.4 | $18M | 18M | 1.00 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 1.2 | $16M | 17M | 0.93 | |
| Inozyme Pharma (INZY) | 1.0 | $14M | 2.4M | 5.57 | |
| Celcuity (CELC) | 1.0 | $13M | 1.3M | 10.18 | |
| Champions Oncology Com New (CSBR) | 0.8 | $11M | 1.7M | 6.38 | |
| Tuya Sponsered Ads (TUYA) | 0.7 | $9.3M | 4.9M | 1.89 | |
| Minerva Surgical | 0.7 | $8.8M | 34M | 0.26 | |
| Glycomimetics (GLYC) | 0.6 | $8.3M | 4.8M | 1.74 | |
| Nkarta (NKTX) | 0.6 | $7.8M | 3.6M | 2.19 | |
| Buzzfeed Class A Com | 0.6 | $7.7M | 15M | 0.51 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.5 | $6.2M | 482k | 12.96 | |
| Inventiva Sa Ads (IVA) | 0.5 | $5.9M | 1.5M | 4.04 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.4 | $5.5M | 2.4M | 2.29 | |
| Gossamer Bio (GOSS) | 0.3 | $4.2M | 3.5M | 1.20 | |
| Marker Therapeutics Com New (MRKR) | 0.3 | $3.3M | 1.1M | 3.10 | |
| Regulus Therapeutics | 0.2 | $2.9M | 1.9M | 1.47 | |
| Senti Biosciences Ord (SNTI) | 0.2 | $2.8M | 4.4M | 0.63 | |
| Affimed Therapeutics B V | 0.2 | $2.6M | 4.4M | 0.60 | |
| Synlogic | 0.1 | $1.8M | 4.2M | 0.43 | |
| Eargo Com New | 0.1 | $1.0M | 208k | 4.93 | |
| Addex Therapeutics Sponsored Ads | 0.0 | $633k | 180k | 3.52 | |
| Wheels Up Experience Com Cl A (UP) | 0.0 | $124k | 106k | 1.17 | |
| Akari Therapeutics Sponsored Adr | 0.0 | $77k | 452k | 0.17 |
